It was a joyous experience for the athlete and his family. It was also an affirmation of the rule learned 20 or so years ago with other organ transplants: transplant survivors, even the ones at extremes at the time of transplantation, can have a complete rehabilitation from their devastating ailments.
Intestinal, combined liver and intestinal or multivisceral transplants have been employed for the treatment of patients who are dependent on parenteral nutrition when the latter is no longer possible. Reasons include the depletion of venous access sites, complications (ie, cholestatic jaundice) or progression of the underlying disease (ie, desmoid tumors in Gardner's syndrome). Because of this precondition to transplantation, they have only been performed on patients who are very seriously ill.
The combination of parenteral nutrition and transplantation has allowed survival of patients whose cases were previously considered nonsalvageable, and has allowed these patients to have an increasingly acceptable length and quality of life.
Intestinal transplantation has developed to its current status with breakthroughs and also with more subtle and systematic, but no less intense, clinical and basic investigations.
Breakthroughs include the first successful case of isolated intestinal transplantation in Paris, France [1] ; combined liver and intestinal transplantation in London, Ontario, Canada [2] ; multivisceral transplantation in Pittsburgh, PA, USA [3] , and in Salzburg, Austria [4] ; and the introduction of tacrolimus for prevention and treatment of intestinal rejection in Pittsburgh, PA, USA.
Intestinal transplants have also provided the impetus for other developments. Chimerism, the two-way cell traffic between graft and host, was first observed in humans after intestinal transplantation [5] . These observations are thought by Starzl to explain the post transplant phenomena of rejection, graft versus host disease and tolerance. Debates notwithstanding, these observations have started a new era in transplant immunology. It is likely that through intestinal transplantation we will acquire a great deal of knowledge on the immunology, physiology and interactions of the abdominal organs.
The more subtle, continual effort and mounting experience with intestinal transplants during the last decade have produced a significant improvement of the results. At this time, patient and graft survival, at least in the short term, after isolated intestinal transplantation are similar to those after more established transplants. Prognosis after the more complex multiple organ transplants is less favorable than expected. This experience is still not widely known because it has been communicated mainly through peer review publications, presentations, and discussions at transplant meetings that are frequently addressed to specialists.
It is the purpose of this review to summarize some of these developments and their impact on the application of intestinal and multivisceral transplantation for the treatment of intestinal and multiple organ failure.
